Development of transferability guidance for integrated care models with special focus on Central and Eastern European countries

被引:5
|
作者
Kalo, Zoltan [1 ,2 ]
Zemplenyi, Antal [2 ,3 ]
Rutten-van Molken, Maureen [4 ,5 ]
Looman, Willemijn [4 ]
Huic, Mirjana [6 ]
Hacek, Romana Tandara [6 ]
Petrova, Guenka [7 ]
Piniazhko, Oresta [8 ]
Tesar, Tomas [9 ]
Csanadi, Marcell [2 ]
Pitter, Janos G. [2 ]
机构
[1] Semmelweis Univ, Ctr Hlth Technol Assessment, Budapest, Hungary
[2] Syreon Res Inst, Mexikoi Str 65-A, Budapest, Hungary
[3] Univ Pecs, Fac Pharm, Div Pharmacoecon, Pecs, Hungary
[4] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands
[5] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands
[6] Minist Hlth, Directorate Hlth Tourism & Qual Hlth Serv, Sect Qual Hlth Serv, Dept Hlth Technol Assessment, Zagreb, Croatia
[7] Med Univ Sofia, Fac Pharm, Sofia, Bulgaria
[8] Minist Hlth, State Expert Ctr, HTA Dept, Kiev, Ukraine
[9] Comenius Univ, Fac Pharm, Dept Org & Management Pharm, Bratislava, Slovakia
基金
欧盟地平线“2020”;
关键词
ECONOMIC EVALUATIONS; IMPLEMENTATION;
D O I
10.3325/cmj.2020.61.252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To develop pragmatic recommendations for Central and Eastern European (CEE) policymakers about transferability assessment of integrated care models established in higher income European Union (EU) countries. Methods Draft recommendations were developed based on Horizon 2020-funded SELFIE project deliverables related to 17 promising integrated care models for multimorbid patients throughout Europe, as well as on an online survey among CEE stakeholders on the relevance of implementation barriers. Draft recommendations were discussed at the SELFIE transferability workshop and finalized together with 22 experts from 12 CEE countries. Results Thirteen transferability recommendations are provided in three areas. Feasibility of local implementation covers the identification and prioritization of implementation barriers and proposals for potential solutions. Performance measurement of potentially transferable models focuses on the selection of models with proven benefits and assurance of performance monitoring. Transferability of financing methods for integrated care explores the relevance of financing methodologies and planning of adequate initial and long-term financing. Conclusions Implementation of international integrated care models cannot be recommended without evidence on its local feasibility or scientifically sound and locally relevant performance assessment in the country of origin. However, if the original financing method is not transferable to the target region, development of a locally relevant alternative financing method can be considered.
引用
收藏
页码:252 / 259
页数:8
相关论文
共 50 条
  • [1] The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries
    Nemeth, Bertalan
    Goettsch, Wim
    Kristensen, Finn Borlum
    Piniazhko, Oresta
    Huic, Mirjana
    Tesar, Tomas
    Atanasijevic, Dragana
    Lipska, Iga
    Kalo, Zoltan
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (04) : 321 - 329
  • [2] Prioritization of implementation barriers related to integrated care models in Central and Eastern European countries
    Csanadi, Marcell
    Kalo, Zoltan
    Rutten-van Molken, Maureen
    Looman, Willemijn
    Huic, Mirjana
    Ercevic, Darija
    Atanasijevic, Dragana
    Lorenzovici, Laszlo
    Petryszyn, Pawel
    Pogany, Gabor
    Pitter, Janos
    Zemplenyi, Antal
    HEALTH POLICY, 2022, 126 (11) : 1173 - 1179
  • [3] TRANSFERABILITY OF INTERNATIONAL EVIDENCE ON THE BENEFITS OF INNOVATIVE MEDICINES INTO CENTRAL EASTERN EUROPEAN COUNTRIES
    Inotai, A.
    Kalo, Z.
    Petrova, G.
    Vitezic, D.
    VALUE IN HEALTH, 2014, 17 (03) : A33 - A33
  • [4] TRANSFERABILITY OF NICE RECOMMENDATIONS FOR PHARMACEUTICAL THERAPIES IN ONCOLOGY TO CENTRAL-EASTERN EUROPEAN COUNTRIES
    Kalo, Z.
    Landa, K.
    Dolezal, T.
    Voko, Z.
    VALUE IN HEALTH, 2011, 14 (03) : A175 - A175
  • [5] Behind the subcutaneous trastuzumab hype: evaluation of benefits and their transferability to Central Eastern European countries
    Inotai, Andras
    Agh, Tamas
    Karpenko, Alexei Willem
    Zemplenyi, Antal
    Kalo, Zoltan
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (02) : 105 - 113
  • [6] PROGRESS IN ECO-INNOVATION FOR GREEN AND RESILIENT DEVELOPMENT IN EUROPEAN UNION WITH A FOCUS ON CENTRAL AND EASTERN EUROPEAN COUNTRIES
    Istrate, M.
    Horea-Serban, R.
    Banica, A.
    JOURNAL OF ENVIRONMENTAL PROTECTION AND ECOLOGY, 2019, 20 (04): : 1814 - 1821
  • [7] Local Economic Development in the Central and Eastern European Countries
    Mezei Cecilia
    TER ES TARSADALOM, 2006, 20 (03): : 95 - 108
  • [8] Regional and local development in central and eastern European countries
    Scharle, P
    TRANSPORT: NEW PROBLEMS, NEW SOLUTIONS: INTRODUCTORY REPORTS AND SUMMARY OF DISCUSSIONS, 1996, : 509 - 530
  • [9] INTEGRATIVE POTENTIAL OF CENTRAL EUROPEAN METROPOLISES WITH A SPECIAL FOCUS ON THE VISEGRAD COUNTRIES
    Martin, Sauer
    Vilem, Paril
    Milan, Viturka
    TECHNOLOGICAL AND ECONOMIC DEVELOPMENT OF ECONOMY, 2019, 25 (02) : 219 - 238
  • [10] HEALTH ECONOMIC VALUE PROPOSITIONS FOR SUBCUTANEOUS TRASTUZUMAB AND THEIR TRANSFERABILITY TO CENTRAL-EASTERN EUROPEAN COUNTRIES
    Inotai, A.
    Agh, T.
    Karpenko, A. W.
    Zemplenyi, A.
    Kalo, Z.
    VALUE IN HEALTH, 2018, 21 : S75 - S75